Abstract:Purpose: Angiostatin (Angio) and endostatin (Endo) are two potent endothelial cell-specific growth inhibitors that have been shown to substantially inhibit angiogenesis in vivo and tumor growth in several murine or human tumor models. Administration of recombinant proteins in tumor-bearing mice results in significant reduction of tumor growth, and even tumor shrinkage, but requires long-term delivery of large doses of these proteins. Transfection of mammary tumor cell lines with angiogenic inhibitor Angio and Endo genes, however, might provide an effective way to achieve the locally higher expression of these antiangiogenic factors in tumor-bearing mice. Materials and Methods: Single CMV promoter-driven hEndo-Angio pBLAST was transfected into murine Mca-35 mammary tumor cells. Secreted endostatin protein was measured in conditioned medium by Western and ELISA. In vitro tumor cell growth was determined by cell proliferation assay. Primary tumor growth and artificial lung metastasis were compared between Endo-Angio transfectants and vector controls. Tumor total structural (CD31-stained) and functional (DiOC7-perfused) vessels were quantitatively determined in these transfectants. Results: Although clone variation existed in hEndo-Angio transfected MCa-35 tumor cells (one of four Endo-Angio transfected positive clones had similar growth rate to the parent), complete loss of tumorigenicity was seen in half of the inoculated animals (2 out of four clones). Three of four positive clones had significant reduction of tumor size compared with vector controls 14 days after inoculation (702±60 vs 36±10 mm3, P<0.05). hEndo-Angio transfectants also had decreases in artificial lung metastasis compared with vector controls. Reduction of tumor growth and lung metastasis in Endo-Angio transfectants was associated with a significant decrease of CD31-stained (total structural) and DiOC7-perfused vessels (functional) in tumors transfected with Endo-Angio genes. Conclusion: These findings imply that the combined angiostatin and endostatin gene transfection is antiangiogenic in mammary tumors, and has physiologic effects that may also produce synergistic antitumor response when combined with radiation.

[Inhibitory Effects of Recombinant Human Endostatin on Growth and Metastasis of Lung Adenocarcinoma LA795 in Mice].

[Inhibitory Effect of Recombinant Human Endostatin on Angiogenesis and Lung Metastasis of Mouse Lung Adenocarcinoma LA795].

[Effects of Endostatin on the Growth and Lymphangiogenesis of Lewis Lung Carcinoma Xenograft in Mice].

Inhibition of Tumor Growth and Metastasis Via Local Administration of Recombinant Human Endostatin Adenovirus

Inhibition of Angiogenesis and the Growth of Murine Colon Cancer with Recombinant Human Endostatin Adenovirus

[Inhibitive Effects of Recombinant Adenovirus-Mediated Human Endostatin on the Growth of Human Hepatocellular Carcinoma Xenograft in Nude Mice].

Inhibitory effect of recombinant adenovirus-mediated mouse endostatin on pulmonary metastasis of osteosarcoma cell line MG-63 in nude mice

Effect of recombinant human endostatin on microenvironment of human lung adenocarcinoma

[Biological Effect of Endostatin on Transplanted Human Lung Adenocarcinoma Calu-6 Tumor in Nude Mice].

Effect Of Endostatin On Preventing Postoperative Progression Of Distant Metastasis In A Murine Lung Cancer Model

Research of the Anti-Tumor Effect of Human Endostatin Mediated by Recombinant Adeno-Associated Virus

Inhibition of Tumor Growth in Xenografted Nude Mice with Adenovirus-Mediated Endostatin Gene Comparison with Recombinant Endostatin Protein.

STUDY OF ANTI-TUMOR EFFECT OF RECOMBINANT HUMAN ENDOSTATIN

Intra-tumoral and intra-muscular administration of human endostatin gene inhibits Tca8113 cell growth

Single or Double Transfection of Angiostatin and Endostatin Genes Affect Mammary Tumor Growth, Lung Metastasis and Structural and Perfused Vessels

Therapeutic Efficacy of Recombinant Human Endostatin Combined with Chemotherapeutics in Mice-Transplanted Tumors

Inhibitory effects of endostatin on rats sarcoma xenografts in different growth stages

Synergistic Anti-Tumor Effect of Recombinant Human Endostatin Adenovirus Combined with Gemcitabine

Retrovirus-mediated Gene Transfer of Human Endostatin Inhibits Growth of Human Liver Carcinoma Cells SMMC7721 in Nude Mice

Inhibition of Tumor Growth in Mice by Endostatin Derived from Abdominal Transplanted Encapsulated Cells

Endostatin Exhibits a Direct Antitumor Effect in Addition to Its Antiangiogenic Activity in Colon Cancer Cells.